Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Cash from Investing Activities: 2020-2025

Historic Cash from Investing Activities for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to -$4.7 million.

  • GeneDx Holdings' Cash from Investing Activities rose 39.56% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.0 million, marking a year-over-year decrease of 47.82%. This contributed to the annual value of -$30.1 million for FY2024, which is 31.09% up from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Cash from Investing Activities is -$4.7 million, which was up 87.11% from -$36.4 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Cash from Investing Activities high stood at $843,000 for Q1 2024, and its period low was -$130.3 million during Q2 2022.
  • Over the past 3 years, GeneDx Holdings' median Cash from Investing Activities value was -$7.8 million (recorded in 2024), while the average stood at -$11.3 million.
  • Per our database at Business Quant, GeneDx Holdings' Cash from Investing Activities plummeted by 2,807.77% in 2022 and then spiked by 282.47% in 2024.
  • Quarterly analysis of 5 years shows GeneDx Holdings' Cash from Investing Activities stood at -$7.7 million in 2021, then skyrocketed by 63.11% to -$2.8 million in 2022, then tumbled by 71.39% to -$4.9 million in 2023, then soared by 89.33% to -$519,000 in 2024, then soared by 39.56% to -$4.7 million in 2025.
  • Its Cash from Investing Activities stands at -$4.7 million for Q3 2025, versus -$36.4 million for Q2 2025 and -$9.4 million for Q1 2025.